Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNA Methylation in Allogeneic Hematopoietic Stem Cell Transplantation (MET_SCT_2018).

NCT03871296 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT03871296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03871296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNA Methylation in Allogeneic Hematopoietic Stem Cell Transplantation (MET_SCT_2018).
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Observational
Overall status
Unknown status
Start date
September 10, 2018
Completion date
September 10, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, stem cell transplant complications